Skip to main content
. 2014 Oct 25;71(1):457–464. doi: 10.1007/s12013-014-0224-x

Fig. 9.

Fig. 9

Changes in Th and CTL lymphocytes following the bortezomib therapy. * p < 0.05; ** p < 0.01